Literature DB >> 19540944

Signaling pathways of cardioprotective ischemic preconditioning.

Umar Sadat1.   

Abstract

BACKGROUND: Ischemia/reperfusion (I/R) injury is a major contributory factor to cardiac dysfunction and infarct size that determines patient prognosis after acute myocardial infarction. During the last 20 years, since the appearance of the first publication on ischemic preconditioning (IP), our knowledge of this phenomenon has increased exponentially. RESULTS AND
CONCLUSION: Basic scientific experiments and preliminary clinical trials in humans suggest that IP confers resistance to subsequent sustained ischemic insults not only in the regional tissue but also in distant organs (remote ischemic preconditioning), which may provide a simple, cost-effective means of reducing the risk of perioperative myocardial ischemia. The mechanism may be humoral, neural, or a combination of both, and involves adenosine, bradykinin, protein kinases and K(ATP) channels, although the precise end-effector remains unclear. This review describes different signaling pathways involved in acute ischemic preconditioning in detail.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19540944     DOI: 10.1016/j.ijsu.2009.06.004

Source DB:  PubMed          Journal:  Int J Surg        ISSN: 1743-9159            Impact factor:   6.071


  13 in total

Review 1.  Regulation of mitochondrial bioenergetic function by hydrogen sulfide. Part II. Pathophysiological and therapeutic aspects.

Authors:  Katalin Módis; Eelke M Bos; Enrico Calzia; Harry van Goor; Ciro Coletta; Andreas Papapetropoulos; Mark R Hellmich; Peter Radermacher; Frédéric Bouillaud; Csaba Szabo
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

2.  Serum from patients undergoing remote ischemic preconditioning protects cultured human intestinal cells from hypoxia-induced damage: involvement of matrixmetalloproteinase-2 and -9.

Authors:  Karina Zitta; Patrick Meybohm; Berthold Bein; Christin Heinrich; Jochen Renner; Jochen Cremer; Markus Steinfath; Jens Scholz; Martin Albrecht
Journal:  Mol Med       Date:  2012-02-10       Impact factor: 6.354

3.  Early ischaemic preconditioning requires Akt- and PKA-mediated activation of eNOS via serine1176 phosphorylation.

Authors:  Changjun Yang; M A Hassan Talukder; Saradhadevi Varadharaj; Murugesan Velayutham; Jay L Zweier
Journal:  Cardiovasc Res       Date:  2012-09-12       Impact factor: 10.787

4.  Cardioprotective effect of remote preconditioning of trauma and remote ischemia preconditioning in a rat model of myocardial ischemia/reperfusion injury.

Authors:  Qing Chai; Jin Liu; Yang Hu
Journal:  Exp Ther Med       Date:  2015-03-02       Impact factor: 2.447

5.  Acclimatization of the systemic microcirculation to alveolar hypoxia is mediated by an iNOS-dependent increase in nitric oxide availability.

Authors:  Alfred J Casillan; Jie Chao; John G Wood; Norberto C Gonzalez
Journal:  J Appl Physiol (1985)       Date:  2017-03-16

Review 6.  Platelet activating factor in heart failure: potential role in disease progression and novel target for therapy.

Authors:  Paraskevi Detopoulou; Tzortzis Nomikos; Elizabeth Fragopoulou; Christina Chrysohoou; Smaragdi Antonopoulou
Journal:  Curr Heart Fail Rep       Date:  2013-06

7.  Angiotensin II and ischemic preconditioning synergize to improve mitochondrial function while showing additive effects on ventricular postischemic recovery.

Authors:  Rebeca E Nuñez; Miriam Castro; Sabzali Javadov; Nelson Escobales
Journal:  J Cardiovasc Pharmacol       Date:  2014-08       Impact factor: 3.105

8.  Update on the Pathophysiological Role of Intracellular Signaling Pathways in Atherosclerotic Plaques and Ischemic Myocardium.

Authors:  Fabrizio Montecucco; Vincent Braunersreuther; Giorgio Luciano Viviani; Sébastien Lenglet; François Mach
Journal:  Curr Signal Transduct Ther       Date:  2012-05

9.  Profiling of cell stress protein expression in cardiac tissue of cardiosurgical patients undergoing remote ischemic preconditioning: implications for thioredoxin in cardioprotection.

Authors:  Karina Zitta; Patrick Meybohm; Matthias Gruenewald; Jochen Cremer; Kai D Zacharowski; Jens Scholz; Markus Steinfath; Martin Albrecht
Journal:  J Transl Med       Date:  2015-01-27       Impact factor: 5.531

10.  Cardiopulmonary Bypass, Inflammation and How to Defy it: Focus on Pharmacological Interventions.

Authors:  Ali Dabbagh; Samira Rajaei; Ayad Bahadori Monfared; Ali Asghar Keramatinia; Korosh Omidi
Journal:  Iran J Pharm Res       Date:  2012       Impact factor: 1.696

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.